This chemical is primarily used in research and therapeutic contexts as a BCL6 inhibitor. BCL6 is a protein involved in the regulation of gene expression, particularly in immune cells, and its dysregulation is often associated with certain types of cancers, such as diffuse large B-cell lymphoma (DLBCL). By inhibiting BCL6, this compound helps to disrupt the survival and proliferation of cancer cells, making it a potential candidate for cancer treatment. It is often studied in preclinical models to evaluate its efficacy and safety in targeting BCL6-dependent cancers. Additionally, it may be used in combination therapies to enhance the effectiveness of other anticancer drugs.